Skip to main content

Peptide Modifications: Linkers, Spacers and PEGylation

Peptide Modifications: Linkers, Spacers and PEGylation

Get a Quote

LifeTein provides custom PEGylated conjugates and fatty acid conjugation services for peptides, and small molecules. PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their hydrodynamic size and shielding them from proteolytic enzymes, PEGylation can improve the pharmacokinetics of peptides and proteins. It commonly reduces renal clearance and can give more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylation can improve water solubility and biocompatibility, and can reduce immunogenicity of the attached molecule, along with other changes to physico-chemical behaviour. How much of each is obtained depends on the PEG size and architecture, the attachment site, and the molecule being modified. It is an established method for the delivery of biopharmaceuticals.

The Glutathione (GSH), a tripeptide formed from glutamic acid, cysteine and glycine, is active in many biological redox reactions. The conjugation of glutathione to its PEGylated liposome can be transported through the blood brain barrier in vivo via a sodium-dependent transporter. The GSH PEGylated liposomes enhance delivery of a fluorescent marker in the brain.

LifeTein will PEGylate your peptide, or small molecule, and deliver your PEGylated product with a certificate of analysis, as a regular end-product, for further testing at your site.

As a global partner, we can supply commercial quantities of high quality functionalized PEGs, which are essential for your PEGylated therapeutic proteins.

Our PEGylation services and fatty acid conjugation include:

  • Multiple choices: amine reactive PEG acid, carbonyl reactive aminooxy PEG, click chemistry alkyne PEG and PEG azide, DBCO PEG, lipid PEG in drug delivery DSPE PEG, thiol reactive PEG Maleimide, fatty acids of C18, C20 and more
  • PEGylation feasibility studies
  • Pilot production and process development of PEG-drug conjugate
  • Development of PEGylated biosimilars

Discover more about Peptide Drug Conjugation and linkers and spacers.

Pharmacological advantages of peptide PEGylation:

  • Improved peptide solubility and enhanced protection from proteolytic degradation. The PEG polymer, along with its associated water molecules, acts like a shield to protect the attached peptide drug from enzyme degradation, thereby limiting adverse immunological effects. PEGylated peptides are more stable over a range of pH and temperature changes compared with their un-PEGylated counterparts.
  • Reduced dosing frequency with potentially reduced toxicity. PEG itself shows little intrinsic toxicity. Clearance of a PEGylated drug depends on the size and architecture of the intact conjugate and on the species: smaller conjugates are cleared predominantly by the kidney, while larger ones shift towards hepatic and faecal routes. The crossover is gradual and not a fixed molecular-weight cut-off.
  • Increased stability and extended circulating life for many conjugates. PEG was long described as non-immunogenic, but that is no longer an accurate statement: anti-PEG antibodies occur both pre-existing in people never knowingly treated with a PEGylated drug — reported in a substantial proportion of healthy donors — and induced by treatment. They have been associated with accelerated blood clearance, reduced efficacy and, in some cases, hypersensitivity reactions. For any application where immune response matters, anti-PEG reactivity is something to evaluate rather than assume away.1

LifeTein can attach the PEGs to peptides. Some examples are listed below:

  • Monofunctional PEG Maleimide, Molecular Weight of 1K, 2K, 5K, 10K, 20K, or 30K
    Pegylation Maleimide
  • Bifunctional Maleimide PEG Maleimide, Molecular Weight of 1K, 2K, 5K, 10K, 20K, or 30K
    Pegylation bi-functional Maleimide
  • DSPE-PEG-MAL, Maleimide functionalized PEG Lipid,Molecular Weight of 1K, 2K, or 5K
  • Biotin PEG Maleimide, FITC, PEG Maleimide, Multi-arm-4/8 arm-PEG Maleimide
  • Fmoc-ε-Ahx-OH, or N-ε-Fmoc-ε-aminocaproic acid; or Fmoc-6-aminohexanoic acid; CAS number: 88574-06-5; Molecular weight: 353.42 g/mol; Molecular Formula: C21H23NO4. Ahx or b-Ala can be used successfully as spacers during the generation of FITC-labeled peptides, which increases the stability of the fluorescent label. FITC can also be linked easily to a cysteine thiol moiety or to the amino group of lysine at any position.Synthesis using an Ahx linker in the lysine core resulted in better yields. Ahx increases the flexibility of peptide chains, which might help keep peptide chains properly solvated during synthesis, thereby preventing aggregation and increasing the amount of viable growing peptide sequences.

Linker/Spacer (Examples)

Fmoc-Glycine 2 Carbons Fmoc-Gly-OH
3-Amino-3-(2-Nitrophenyl)
Propanoic Acid (ANP Linker)
3 Carbons ANP-Linker
Fmoc-beta-Ala-OH 3 Carbons Fmoc-beta-Ala-OH

4-Aminobutyric Acid (GABA)

Fmoc-GABA-OH

4 Carbons Fmoc-GABA-OH
5-Aminovaleric Acid (Ava) 5 Carbons Fmoc-5-Ava-OH
Aminohexanoic Acid (Ahx) 6 Carbons

Fmoc-Ahx-OH

mini-PEG or AEEA

Fmoc-NH-PEG2-CH2COOH

Length of Bonds: 9

Fmoc-NH-PEG2-CH2COOH

mini-PEG2 or AEEP

Fmoc-NH-PEG2-CH2CH2COOH

Length of Bonds: 10

Fmoc-NH-PEG2-CH2CH2COOH

AEEEA

Fmoc-NH-PEG3-CH2COOH

Length of Bonds: 12

Fmoc-NH-PEG3-CH2COOH-AEEEA

AEEEP, or PEG3

Fmoc-NH-PEG3-CH2CH2COOH

Length of Bonds: 13

Fmoc-NH-PEG3-CH2CH2COOH

AEEEEP, PEG4

Fmoc-NH-PEG4-CH2CH2COOH

Length of Bonds: 16

Fmoc-NH-PEG4-CH2CH2COOH

AEEEEEP, PEG5

Fmoc-NH-PEG5-CH2CH2COOH

Length of Bonds: 19

Fmoc-NH-PEG5-CH2CH2COOH

1. Short-Chain Fatty Acids (Usually fewer than 6 carbon atoms)

Name Carbon Atoms Formula Saturation
Formic acid C1 HCOOH Saturated
Acetic acid C2 CH₃COOH Saturated
Propionic acid C3 CH₃CH₂COOH Saturated
Butyric acid C4 CH₃(CH₂)₂COOH Saturated
Valeric acid C5 CH₃(CH₂)₃COOH Saturated

2. Medium-Chain Fatty Acids (6 to 12 carbon atoms)

Name Carbon Atoms Formula Saturation
Caproic acid C6 CH₃(CH₂)₄COOH Saturated
Caprylic acid C8 CH₃(CH₂)₆COOH Saturated
Capric acid C10 CH₃(CH₂)₈COOH Saturated
Lauric acid C12 CH₃(CH₂)₁₀COOH Saturated

3. Long-Chain Fatty Acids (13 to 21 carbon atoms)

Name Carbon Atoms Formula Saturation
Myristic acid C14 CH₃(CH₂)₁₂COOH Saturated
Palmitic acid C16 CH₃(CH₂)₁₄COOH Saturated
Stearic acid C18 CH₃(CH₂)₁₆COOH Saturated
Oleic acid C18:1 CH₃(CH₂)₇CH=CH(CH₂)₇COOH Monounsaturated
Linoleic acid C18:2 CH₃(CH₂)₄(CH=CHCH₂)₂(CH₂)₆COOH Polyunsaturated
Arachidic acid C20 CH₃(CH₂)₁₈COOH Saturated

4. Very-Long-Chain Fatty Acids (22 or more carbon atoms)

Name Carbon Atoms Formula Saturation
Behenic acid C22 CH₃(CH₂)₂₀COOH Saturated
Lignoceric acid C24 CH₃(CH₂)₂₂COOH Saturated
Cerotic acid C26 CH₃(CH₂)₂₄COOH Saturated

{PEGn}: Fmoc-NH-PEGn-CH2CH2COOH

  • {mini-PEG}, or {AEEA}, Fmoc-NH-PEG2-CH2COOH, CAS number: 166108-71-0; 2-[2-[2-(Fmoc-amino)ethoxy]ethoxy]acetic acid; Molecular weight: 385.42 g/mol; C21H23NO6
    Mini-PEG 9 atoms AEEA
  • {mini-PEG2}, {AEEP}: Fmoc-NH-PEG2-CH2CH2COOH, CAS number: 872679-70-4; Fmoc-NH-PEG2-Propionic Acid; 9-(Fmoc-amino)-4,7-dioxanonanoic acid; Molecular weight: 399.5 g/mol; C22H25NO6

    Fmoc-NH-PEG2-Propionic Acid
  • {AEEEA}: Fmoc-NH-PEG3-CH2COOH, CAS number: 139338-72-0; Molecular weight: 429.46 g/mol; C23H27NO7
    Fmoc-NH-PEG3-CH2COOH-AEEEA
  • {AEEEP}, or {PEG3}: Fmoc-NH-PEG3-CH2CH2COOH, CAS number: 867062-95-1; Molecular weight: 443.50 g/mol; C24H29NO7
    Fmoc-NH-PEG3-CH2CH2COOH
  • {AEEEEP}, or {PEG4}: Fmoc-NH-PEG4-CH2CH2COOH, CAS number: 557756-85-1; Fmoc-NH-PEG4-Propionic Acid, or Fmoc-15-amino-4,7,10,13-tetraoxapentadecanoic acid; Molecular weight: 487.6 g/mol; C26H33NO8
    Fmoc-NH-PEG4-CH2CH2COOH
  • {AEEEEEP}, or {PEG5}: Fmoc-NH-PEG5-CH2CH2COOH, CAS number: 882847-32-7; Fmoc-NH-PEG5-Propionic acid, or Fmoc-18-amino-4,7,10,13,16-pentaoxaoctadecanoic acid; Molecular weight: 531.6 g/mol; C28H37NO9
    Fmoc-AEEEEEP
Other PEGs are available.
Fmoc-NH-PEG6 -CH2CH2COOH, CAS number: 882847-34-9, Molecular weight: 575.60 g/mol;

Fmoc-NH-PEG7 -CH2CH2COOH, CAS number: 1863885-74-8, Molecular weight: 619.58 g/mol;

Fmoc-NH-PEG8-CH2CH2COOH, CAS number: 756526-02-0, Molecular weight: 663.58 g/mol;

Fmoc-NH-PEG9-CH2CH2COOH, CAS number: 1191064-81-9, Molecular weight: 707.58 g/mol;

Fmoc-NH-PEG10-CH2CH2COOH, CAS number: 2101563-45-3, Molecular weight: 751.84 g/mol;

Fmoc-NH-PEG11-CH2CH2COOH, CAS number: 2291257-76-4, Molecular weight: 795.84 g/mol;

Fmoc-NH-PEG12-CH2CH2COOH, CAS number: 756526-01-9, Molecular weight: 839.95 g/mol;

Please click here to get a peptide synthesis service quote now!

                        Get a Quote

Reference

  1. Kozma GT, Shimizu T, Ishida T, Szebeni J. Anti-PEG antibodies: properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals. Adv Drug Deliv Rev. 2020;154–155:163–175.